Upon entry into the circulation, tumour cells will quickly encounter platelets and granulocytes, and the release of platelet-derived chemokines CXCR5/7 from tumour-bound platelets actively recruits granulocytes to platelet-tumour aggregates (51). Here, CXCR5 is linked to neoplasm.